CTA
NGVT icon

Carillon Tower Advisers’s Ingevity NGVT Stock Holding History

Carillon Tower Advisers’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,509
Closed -$184K – 486
2018
Q1 		$184K Sell
2,509
-5,056
-67% -$378K ﹤0.01% 453
2017
Q4 		$533 Buy
+7,565
New +$546K 0.01% 280

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIC
Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Carillon Tower Advisers's NGVT Position: Q2 2018 in Review

Carillon Tower Advisers sold out of Ingevity (NGVT) in Q2 2018, closing a stake of 2,509 shares — an estimated $184K sold.

Carillon Tower Advisers first reported a position in NGVT in Q4 2017 and held it in 2 quarters. The position peaked at $184K in Q1 2018. 309 funds tracked by Wall St. Rank hold NGVT as of Q2 2018.

  • Carillon Tower Advisers reported no remaining Ingevity position as of Q2 2018 after selling out during the quarter.
  • Carillon Tower Advisers sold 2,509 Ingevity shares in Q2 2018, an estimated $184K.
  • Carillon Tower Advisers first reported a position in Ingevity in Q4 2017 and held it in 2 quarters.
  • Carillon Tower Advisers's Ingevity position peaked at $184K in Q1 2018.
  • 309 funds tracked by Wall St. Rank held Ingevity as of Q2 2018.

Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.